Elicio Therapeutics, Inc. 13D and 13G filings for Angion Biomedica Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-04-27 4:10 pm Sale |
2021-12-31 | 13G | Angion Biomedica Corp. ANGN |
Elicio Therapeutics Inc. ELTX |
181,512 6.000% |
-108,662 (-37.45%) |
Filing |
| 2022-04-27 4:08 pm Purchase |
2021-02-04 | 13D | Angion Biomedica Corp. ANGN |
Elicio Therapeutics Inc. ELTX |
290,174 9.300% |
290,174 (New Position) |
Filing |